Horace Mann Educators (NYSE:HMN – Get Free Report) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 2.400-2.700 for the period, compared to the consensus estimate of 2.550. The company issued revenue guidance of -. Horace Mann Educators also updated its FY24 guidance to $2.40-2.70 EPS.
Horace Mann Educators Trading Up 0.1 %
Horace Mann Educators stock traded up $0.03 during mid-day trading on Monday, hitting $37.38. The company’s stock had a trading volume of 194,812 shares, compared to its average volume of 238,030. Horace Mann Educators has a one year low of $31.53 and a one year high of $39.25. The stock has a market cap of $1.52 billion, a PE ratio of 19.10 and a beta of 0.27. The company has a 50 day moving average of $35.50 and a 200-day moving average of $34.75. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.08 and a current ratio of 0.08.
Horace Mann Educators (NYSE:HMN – Get Free Report) last issued its earnings results on Wednesday, August 7th. The insurance provider reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.01. The business had revenue of $388.10 million for the quarter, compared to the consensus estimate of $288.67 million. Horace Mann Educators had a net margin of 5.24% and a return on equity of 7.44%. The company’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.03 EPS. On average, research analysts anticipate that Horace Mann Educators will post 2.63 EPS for the current year.
Horace Mann Educators Dividend Announcement
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on HMN. Raymond James started coverage on Horace Mann Educators in a research report on Tuesday, August 6th. They set a “strong-buy” rating and a $42.00 price objective on the stock. Keefe, Bruyette & Woods cut their price objective on shares of Horace Mann Educators from $40.00 to $39.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 13th. Finally, Piper Sandler increased their target price on shares of Horace Mann Educators from $34.00 to $36.00 and gave the company a “neutral” rating in a research report on Wednesday, October 2nd. Three investment analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Horace Mann Educators presently has an average rating of “Moderate Buy” and a consensus price target of $39.00.
Get Our Latest Analysis on HMN
Insiders Place Their Bets
In other Horace Mann Educators news, CEO Marita Zuraitis sold 42,117 shares of the stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $37.06, for a total transaction of $1,560,856.02. Following the transaction, the chief executive officer now owns 294,402 shares in the company, valued at approximately $10,910,538.12. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 3.80% of the company’s stock.
About Horace Mann Educators
Horace Mann Educators Corporation, together with its subsidiaries, operates as an insurance holding company in the United States. The company operates through Property & Casualty, Life & Retirement, and Supplemental & Group Benefits segments. Its Property & Casualty segment offers insurance products, including private passenger auto insurance, residential home insurance, and personal umbrella insurance; and provides auto coverages including liability and collision, and property coverage for homeowners and renters.
Featured Articles
- Five stocks we like better than Horace Mann Educators
- The Most Important Warren Buffett Stock for Investors: His Own
- Intel: Is Now the Time to Be Brave?Â
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- The 3 Best Fintech Stocks to Buy Now
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Horace Mann Educators Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horace Mann Educators and related companies with MarketBeat.com's FREE daily email newsletter.